Indication
Non-Hodgkin's Lymphomas, B-Cell
3 clinical trials
4 products
Clinical trial
Efficacy and Safety of Obinutuzumab in Chinese Patients With Indolent Non-Hodgkin's B-cell Lymphoma in the Real-World.Status: Not yet recruiting, Estimated PCD: 2024-12-30
Product
ObinutuzumabClinical trial
A Phase I Dose Escalation Trial of Autologous Third-generation Anti-CD19 Chimeric Antigen Receptor T-cells (WZTL-002) for Relapsed and Refractory B-cell LymphomasStatus: Recruiting, Estimated PCD: 2024-05-01
Product
WZTL002-1Clinical trial
Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse Large B Cell Lymphoma (DLBCL): The AvR-CHOP StudyStatus: Active (not recruiting), Estimated PCD: 2022-06-16
Product
Avelumab